AutoGen is excited to add sample storage and identification to our product portfolio with the addition of AltemisLab’s products. We now offer a wide selection of 2D barcoded tubes, barcode readers, de-capping, re-capping, and other tools that help busy labs better manage their samples, reduce handling times and avoid costly misidentification or mishandling errors. The…
New agreement sees Isohelix GeneFixTM Saliva DNA and RNA Collection Devices integrated into AutoGen FlexSTAR DNA extraction workflows. Harrietsham, UK & Holliston, USA – (April 28, 2021) – Isohelix, a specialist provider of DNA and RNA sampling and purification products, and AutoGen, Inc., a leading provider of nucleic acid extraction automation have signed a far-reaching…
AutoGen introduces a new addition to their instrumentation portfolio, the NeXTRACT 48, a fully automated workflow for extracting viral DNA and RNA. Holliston, MA, December 15, 2020: Autogen, Inc. is pleased to announce the introduction of their newest fully automated workflow, the NeXTRACT 48. The NeXTRACT 48 is designed for the rapid extraction of…
Developed in collaboration with DNA Genotek Inc., the new protocol can process up to 30, 4 ml of saliva collected with an Oragene® device in a single well. Holliston, MA, December 1, 2020: AutoGen Inc. is pleased to announce the launch of a new laboratory-based saliva sample processing protocol for their portfolio of FlexSTAR workflows.…
The new AutoGen vortex module upgrade enables a 35% improvement in throughput Holliston, MA, September 16, 2020: AutoGen Inc. is excited to announce the launch of the vortex module upgrade to their portfolio of FlexSTAR workflows. FlexSTAR workflows are fully automated instruments for isolating genomic DNA from large volumes of whole blood, buffy coats, saliva,…
Dear Colleagues, Thank you for your support and patience as the number of cases and countries impacted by COVID-19 increases each day. AutoGen continues to be fully operational while still practicing safe social distancing both in and out of the office during this ongoing pandemic. We are working closely with our supply chain partners to…
Dear Colleagues, We at AutoGen continue to monitor the global COVID-19 pandemic and above all else are committed to protecting the health, safety and well-being of our employees, customers and partners. The spread of the COVID-19 virus presents unique challenges and our actions are intended to promote social distancing and enable continuity of services in…
Thank you to everyone who participated in our recent webinar, The Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations. Please click here to view the webinar video.
NEW YORK – Researchers at the Colorado Center for Personalized Medicine’s (CCPM) Biobank are collecting patient samples in order to analyze genetic data using SNP microarrays to provide pharmacogenetic (PGx) results. Read the Article >
AutoGen19-CEOCFOMagazine-Interview Interview conducted by: Lynn Fosse, Senior Editor, CEOCFO Magazine, Published – September 16, 2019 CEOCFO: Mr. Messier, what is the focus for AutoGen, today? Mr. Messier: AutoGen’s primary focus is to provide optimal workflows for automated nucleic acid extractions with an unmatched level of customer support and service. Our customers include biorepositories, contract research…